Approaches to patients with obesity and CKD: focus on nutrition and surgery

Obesity is recognized as a public health challenge. During the last three decades, the global age-standardized prevalence increased from 8.8% to 18.5% in women and from 4.8% to 14.0% in men, with an absolute current number of 878 million obese subjects. Obesity significantly increases <i>per se</i> the risk of developing disability and chronic diseases, including chronic kidney disease (CKD). Specifically, obesity acts as a major, modifiable cause of CKD onset and progression toward kidney failure; as such, it is considered by the International Society of Nephrology a major health priority. This review analyses the effectiveness, safety and practicability of non-pharmacological anti-obesity interventions in CKD as the different patient phenotypes that may take advantage of personalized approaches.

Authors

Institutions

Publication Details

Journal
Clinical Kidney Journal
Published
2024-11-22
DOI
https://doi.org/10.1093/ckj/sfae291
Citations
4
Primary Topic
Bariatric Surgery and Outcomes
Type
article
Field-Weighted Citation Impact
2.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Approaches to patients with obesity and CKD: focus on nutrition and surgery

Carlo Garofalo, Vincenzo Bellizzi, Claudia D’Alessandro, Adamasco Cupisti et al.
4 citations
Clinical Kidney Journal
Bariatric Surgery and Outcomes
2.29
article

Approaches to patients with obesity and CKD: focus on nutrition and surgery

Carlo Garofalo, Vincenzo Bellizzi, Claudia D’Alessandro, Adamasco Cupisti, Giuseppe Annunziata, Carmine Zoccali, Luigi Barrea, Mirto Foletto, Luca De Nicola, Alice Albanese
article en
4 citations

Abstract

Obesity is recognized as a public health challenge. During the last three decades, the global age-standardized prevalence increased from 8.8% to 18.5% in women and from 4.8% to 14.0% in men, with an absolute current number of 878 million obese subjects. Obesity significantly increases <i>per se</i> the risk of developing disability and chronic diseases, including chronic kidney disease (CKD). Specifically, obesity acts as a major, modifiable cause of CKD onset and progression toward kidney failure; as such, it is considered by the International Society of Nephrology a major health priority. This review analyses the effectiveness, safety and practicability of non-pharmacological anti-obesity interventions in CKD as the different patient phenotypes that may take advantage of personalized approaches.

Clinical Kidney JournalVol. 17(Supplement_2)
University of Pisa (IT), University of Padua (IT), University of Campania "Luigi Vanvitelli" (IT), Renal Research Institute (US), Pegaso University (IT), University of Campania "Luigi Vanvitelli" (IT), Azienda Ospedale - Università Padova (IT), Ospedale Sant'Anna (IT)
Openalex Percentile: Top 11%
Bariatric Surgery and Outcomes
2.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.